Avidia starts new first-in-class study for Crohn's
Avidia has initiated a clinical trial for the novel inhibitor of a protein for Crohn's disease as a potential treatment that belongs to a new class of therapeutic proteins known as Avimer proteins.
Archives for September 21, 2006
Indian clinical trials "of no more ethical risk than in US"
Conducting clinical trials in India poses no additional ethical risk to patients than trials conducted in the Western World, says an industry veteran.
Enzyme shape changes could redefine drug R&D approach
A key study performed by US scientists has uncovered detailed structural changes, which a catalytic enzyme undergoes in order to carry out its biological function. The findings challenge traditional hypothesis and may aid in future drug design.
Merck acquires Serono for €10.4bn
German drug manufacturer, Merck has acquired the Swiss biotech company Serono in a deal worth SFr16.6bn (€10.4bn) that has taken the industry by surprise and could signal the start of considerable consolidation for big pharma.
ChemBridge enters into alliance with AstraZeneca
AstraZeneca has entered into an agreement with two Contract Research Organisations (CROs) with the intention of expanding AstraZeneca's small molecule libraries and enhancing its global drug discovery offerings.
Bentley Pharma to use Cardinal's facility for nasal insulin manufacture
Bentley Pharmaceuticals has announced it will use the North Carolina facilities of US-based services provider Cardinal Health for the scale-up and manufacture of the clinical supplies of its new intranasal insulin product.